Advanced

PARLIAMENTARY WRITTEN QUESTION
Tirzepatide (8 November 2024)

Question Asked

To ask the Secretary of State for Health and Social Care, what information his Department holds on the potential thyroid cancer risk from Mounjaro; when his Department received this information; whether he has made an assessment of the potential impact of the provision of Mounjaro through the NHS on the risk of thyroid cancer; whether the Medicines and Healthcare products Regulatory Agency has requested information from the US Food and Drug Administration on its interim report on this matter of March 2024; and for what reason the risk-labelling for Mounjaro is different in the UK to that used in the US.

Asked by:
Richard Tice (Reform UK)

Answer

                

                Answered by: 

                 ()

1 January 1970            

        

            
                            
                            
                        

                    


                                    

                    

                        

                    

                

            
                    

                                    

                

                    
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.